Dr. Kristin Neumann, CEO & Co-Founder of MyMicrobiome, is dedicating her career to the microbiome topic. She is consulting us in all matters concerning the human microbiome. The close and intensive cooperation between Lysando and MyMicrobiome ensures being aware of the latest scientific studies and knowledge. This enables us to research on Artilysin®s profiting the human microbiome and consequently the human health.

 

The human microbiome outnumbers the human genome by a factor of

 

150 to 1

Number of different species and where they live:

1

in the mouth,
pharynx & respiratory
system

1

on the skin

1

in the
urogenital tract

1

in the
stomach

1

in the
intestines

These microbes are generally not harmful to us, but actually essential for staying healthy.

They are responsible for some vital processes like

  • breaking down our food to extract nutrients we need to survive,
  • producing vitamins,
  • teaching our immune systems how to recognize dangerous invaders &
  • producing anti-inflammatory compounds fighting disease-causing microbes.

 

Pathogenic bacteria have to reach a certain number before they are able to establish an infection or to cause other unpleasant side effects.

However, when treated with antiseptics or antibiotics, commensal bacteria get killed too – leaving us without a line of defense.

 

Our microbiome is suffering as a result of different circumstances.
(see picture below)

 

Consequences of a damaged microbiome:

  • Vulnerably towards pathogens
  • Diarrhea, when the gut loses microbes necessary for a healthy digestion
  • Obesity
  • Gastrointestinal cancers
  • Inflammatory bowel disease
  • Allergies
  • Diabetes
  • Depression
  • Atopic Dermatitis
  • Acne
  • etc.

 

Artilysin® is the solution.

 

Artilysin®s specificity ensures the preservation of the natural human microbiome by only eliminating the target bacteria you request.

Artilysin® is the only technology able to target gram-negative and gram-positive species, working on persistent and resistant strains and the scientists around it already developed 450 prototypes.

 

Artilysin® supports the recovery of a healthy microbiome.

Application observations showed that the following species returned during the application of Artilysin® – they are all part of a healthy skin microbiome:

  • Micrococcus luteus
  • Coagulase-negative Staphylococcus species (e.g. S. caprae, S. simulans, S. capitis, S. epidermidis and S. pasteuri)
  • Corynebacterium species (e.g. C. striatum)
  • Kocuria species

 

Artilysin® - The technology that restores the microbiome

 

Are you planning to develop a microbiome friendly product which optimizes your customers’ microbiome?

Contact us!

Artilysin® - The technology benefiting your customers

 

Headquarters

Lysando AG
Wangerbergstrasse 91
FL-9497 Triesenberg

Research & Development

Lysando Innovations Lab GmbH
Am BioPark 13
D-93053 Regensburg

What is the sum of 7 and 3?